Source: Annual Congress 2003 - Lung cancer: clinical and biological presentation
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. V. Bazhin, M. S. Savchenko, O. N. Shifrina, S. Y. Chikina, A. G. Chuchalin, P. P. Philippov (Moscow, Russia). Extracts of lung cancer cells reveal the patterns of anti-tumor antibodies in sera of patients with lung cancer. Eur Respir J 2003; 22: Suppl. 45, 2285

Member's Comments

No comment yet.

Related content which might interest you: Extracts of lung cancer cells reveal antitumour antibodies in sera of patients with lung cancer Source: Eur Respir J 2003; 21: 342-346 Year: 2003 EpCAM-positive circulating cells in lung cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Antirecoverin autoantibodies in sera of patients with non-small cell lung cancer in the absence of cancer-associated retinopathy Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Small cell lung cancer patients and their responses to treatment Source: Eur Respir J 2004; 24: Suppl. 48, 301s Year: 2004 Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002 Analysis of the patients with primary lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 562s Year: 2007 Ras peptide-specific vaccination in patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2006 - Lung cancer treatment Year: 2006 Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: ERS Lung Science Conference 2017 Year: 2017 Does expression of betatubulin 3 correlate between primary non small cells lung cancer tumor and metastases? Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Second primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Circulating CD133(+) stem cells in lung cancer patients Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Does the lung function affect the survival time in patients with resected non-small cell lung cancer? Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery Year: 2007 The assessment of immune cells profile in blood and induced sputum in patients with COPD developing lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 674s Year: 2006 Immunotherapies for lung cancer Source: International Congress 2018 – ME12 Immunotherapies for lung cancer FULLY BOOKED Year: 2018 Small cell lung cancer in patients with elderly Source: Annual Congress 2007 - Therapy of lung cancer Year: 2007 Immunomodulating properties of FasL+ lung cancer cells identified in lymph nodes aspirates of NSCLC patients Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer Year: 2020